Yale University
Clinical trials sponsored by Yale University, explained in plain language.
-
Money and mind: can financial coaching ease mental health struggles after incarceration?
Disease control OngoingThis study tests whether combining one-on-one financial coaching with access to safe, affordable banking services can improve both financial health and mental well-being for people recently released from jail or prison. Participants, who self-identify as having mental health or s…
Phase: NA • Sponsor: Yale University • Aim: Disease control
Last updated Jul 02, 2026 03:00 UTC
-
Phone app aims to help heart failure patients in uganda stay healthy
Disease control OngoingThis study tests a new way to help people with heart failure in Uganda manage their condition. It combines a standard care program with a mobile app that tracks symptoms and gives advice. The goal is to see if this approach improves self-care and reduces deaths or hospital stays.…
Phase: NA • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Brain implant study tests new epilepsy drug
Disease control OngoingThis early-phase study tested a new drug called BHV-7000 in 5 people with epilepsy who have a brain implant (RNS) that records brain activity. The goal was to see if the drug reduces abnormal electrical activity linked to seizures. Participants took the drug for 4 weeks, and thei…
Phase: PHASE1 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Can pills or counseling boost weight loss after surgery?
Disease control OngoingThis study looks at whether adding a combination of two drugs (naltrexone and bupropion) or a behavioral weight-loss program can help people who didn't lose enough weight after bariatric surgery. About 84 participants will receive either the drugs, behavioral therapy, both, or a …
Phase: PHASE3 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New hope for hard-to-treat endometrial cancer: targeted drug shows promise in early trial
Disease control OngoingThis study tests a drug called sacituzumab govitecan in 50 people with endometrial cancer that has returned or not responded to platinum chemotherapy. The drug works by delivering chemotherapy directly to cancer cells. The main goal is to see how many patients' tumors shrink or d…
Phase: PHASE2 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New study aims to boost addiction treatment access in communities hardest hit by opioid overdoses
Disease control OngoingThis study looks at ways to help people of color living in areas with high overdose rates start and continue medication-assisted treatment (MAT) for opioid or alcohol use. Researchers will track how many treatment sessions people attend and whether they stick with their medicatio…
Phase: NA • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Could a common heart pill curb stress drinking?
Disease control TerminatedThis small pilot study tested whether propranolol, a beta blocker usually used for high blood pressure, can reduce alcohol drinking triggered by stress. Twenty adults with alcohol use disorder were randomly assigned to take propranolol or a placebo for about two weeks, then compl…
Phase: PHASE2 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Could a Pre-IVF pill boost baby chances for endometriosis patients?
Disease control OngoingThis Phase 3 trial tests whether taking Elagolix, a hormone-blocking drug, before IVF can increase live birth rates in women with endometriosis. About 97 women will receive either Elagolix or a placebo before their IVF cycle. The goal is to see if this pre-treatment improves the …
Phase: PHASE3 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Hospital alcohol therapy boosts recovery engagement
Disease control OngoingThis study tests whether starting alcohol use disorder treatment while still in the hospital helps people stay in treatment and drink less after they go home. 450 adults with moderate to severe alcohol problems will receive either a brief counseling session alone, or that session…
Phase: NA • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New drug combo aims to boost myeloma treatment
Disease control OngoingThis study tests whether combining two approved drugs, belantamab mafodotin and elotuzumab, is safe and works better than either alone for multiple myeloma. About 24 adults whose cancer has returned or not responded to at least three prior treatments will receive the combination.…
Phase: PHASE1, PHASE2 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New app aims to help people cut down on drinking
Disease control ENROLLING_BY_INVITATIONThis pilot study tests a web-based program called Let's Do Addiction Recovery Together! (LDART) for adults with alcohol use disorder. Participants use the website to set daily goals, watch motivational messages from people in recovery, and find local support groups. The study wil…
Phase: NA • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New digital app aims to curb cocaine and meth use
Disease control ENROLLING_BY_INVITATIONThis pilot study tests a web-based program called LDART for adults with stimulant use disorder (cocaine or methamphetamine). The program includes daily goal setting, motivational messages from people in recovery, and links to support groups. Researchers want to see if it's feasib…
Phase: NA • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New drug combo takes on deadly brain tumor
Disease control OngoingThis early-phase trial tests a combination of two drugs (domvanalimab and zimberelimab) that aim to help the immune system fight glioblastoma, an aggressive brain cancer that has returned after initial treatment. About 46 participants will receive the drugs to check safety and se…
Phase: EARLY_PHASE1 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Can a weekly shot help obese teens avoid diabetes and fatty liver?
Disease control OngoingThis study tests whether semaglutide (Wegovy), a once-weekly injection, can preserve the pancreas's ability to produce insulin and reduce liver fat in 60 obese youth with prediabetes or early type 2 diabetes and fatty liver disease. Participants receive either semaglutide or a pl…
Phase: PHASE2 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Could a Stop-Smoking drug curb heavy drinking in HIV patients?
Disease control OngoingThis pilot study tests whether giving the smoking-cessation drug varenicline to people with HIV who also have alcohol use disorder is practical and safe. Thirty participants will receive the medication along with support from a pharmacist and psychiatrist. The goal is to see if t…
Phase: PHASE2 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New combo treatment targets Post-Surgery binge eating
Disease control OngoingThis study tests whether a combination of medication (naltrexone/bupropion, also known as Contrave) and behavioral weight-loss counseling can help people who experience loss-of-control eating after bariatric surgery. About 160 adults who had gastric bypass or sleeve gastrectomy a…
Phase: PHASE2, PHASE3 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Could a common pill protect stroke survivors from another stroke?
Disease control OngoingThis study tests whether adding spironolactone to standard blood pressure treatment helps lower blood pressure more effectively in people who have had a stroke. About 160 adults who had a bleeding or clot-caused stroke are taking spironolactone or continuing their usual care. Res…
Phase: PHASE2 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Green tea extract may boost fertility in women with fibroids
Disease control OngoingThis study tests whether a low-caffeine green tea extract (EGCG) can shrink uterine fibroids and improve pregnancy and live birth rates in women aged 18-40 who have been trying to conceive for at least six months. Participants take the extract and are monitored for changes in fib…
Phase: PHASE3 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New hope for hard-to-treat ovarian cancer: targeted drug shows promise in early trial
Disease control OngoingThis study tests a drug called sacituzumab govitecan in 20 people with ovarian, fallopian tube, or primary peritoneal cancer that has stopped responding to platinum-based chemotherapy. The drug works like a guided missile, delivering chemotherapy directly to cancer cells. The mai…
Phase: PHASE2 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Could an arthritis drug curb alcohol cravings?
Disease control OngoingThis early-stage study tests whether a drug called apremilast can help people with Alcohol Use Disorder drink less alcohol. Ten adults will take the medicine and then have their drinking measured in a lab setting. The goal is to see if the drug reduces alcohol consumption, especi…
Phase: PHASE1 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New program aims to make HIV injections easier for women facing homelessness or food insecurity
Disease control OngoingThis study tests a pharmacist-led program to help women with HIV who also face social challenges like housing or food insecurity. The program supports switching from daily pills to a long-acting injectable medication (cabotegravir/rilpivirine) given every two months. The goal is …
Phase: PHASE2 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Can a Phone-Based program help people with chronic pain cut back on opioids?
Disease control OngoingThis study compares two telemedicine approaches for people with chronic pain and opioid misuse. One program provides standard medication management via remote visits, while the other adds a 12-week self-help program with phone-based coaching. The goal is to see which approach bet…
Phase: NA • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Can a pill keep weight off after bariatric surgery? new trial investigates
Disease control OngoingThis study tests whether the medication naltrexone/bupropion (Contrave) can help people who had bariatric surgery maintain control over eating and avoid weight regain. About 100 adults who previously responded to treatment for loss-of-control eating will receive either the medica…
Phase: PHASE2, PHASE3 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Can surgery boost survival in metastatic prostate cancer?
Disease control OngoingThis study looks at whether surgically removing the prostate, along with hormone therapy and possibly chemotherapy, can help men whose prostate cancer has already spread. About 190 men with newly diagnosed stage IV prostate cancer will be randomly assigned to get either standard …
Phase: PHASE2 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Cancer immunotherapy side effect study pulled before it began
Disease control TerminatedThis study was designed to test whether the drug etrasimod (VELSIPITY) could help reduce the need for steroids in cancer patients who develop diarrhea and colon inflammation from immune checkpoint inhibitors. It planned to enroll about 0 participants with advanced cancer who had …
Phase: PHASE2 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
New community program aims to tame childhood asthma
Disease control OngoingThis pilot study tests a community-academic partnership to help children with asthma in New Haven. It offers home visits from trained community health workers (Promotoras) and an online tool for doctors to guide asthma care. The goal is to see if this approach is feasible and can…
Phase: NA • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New combo attack shows promise against tough pancreatic tumors
Disease control OngoingThis study tests a two-step treatment for people with pancreatic cancer that hasn't spread but can't be removed by surgery. First, patients receive a stronger chemotherapy cocktail (modified FOLFIRINOX), followed by precise, high-dose radiation (SBRT). The goal is to see if this …
Phase: PHASE2 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Could a common diabetes drug speed up heart and kidney healing?
Disease control OngoingThis study tests whether a diabetes drug called dapagliflozin can help people with heart failure who also develop kidney injury recover faster. About 30 adults will take the drug or usual care for three days. The main goal is to see if a larger trial is possible, not to prove the…
Phase: PHASE2 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Could a postpartum depression drug curb alcohol cravings in PTSD?
Disease control OngoingThis early study tests whether brexanolone, a drug already approved for postpartum depression, can safely reduce stress-induced alcohol use in 25 adults with both PTSD and alcohol use disorder. Participants receive a continuous 20-hour IV infusion under medical supervision. The m…
Phase: PHASE1 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Which weight loss surgery works best for teens? study aims to find out
Disease control OngoingThis study follows 26 severely obese teenagers aged 14-19 who chose to have one of three weight loss surgeries: gastric band, sleeve gastrectomy, or gastric bypass. Researchers track weight, body fat, blood sugar, and vitamin levels over time to see which surgery is safest and mo…
Sponsor: Yale University • Aim: Disease control
Last updated Jun 26, 2026 18:19 UTC
-
Could a blood pressure boost save brain cells during a stroke?
Disease control TerminatedThis pilot study tests whether temporarily raising blood pressure with drugs like phenylephrine or norepinephrine can reduce brain damage in people having a major stroke. About 40 adults with large-vessel blockage strokes will receive the blood pressure boost during standard clot…
Phase: EARLY_PHASE1 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 26, 2026 14:05 UTC
-
AI stethoscope? new study uses smart tech to spot hidden heart danger
Diagnosis ENROLLING_BY_INVITATIONThis study tests whether artificial intelligence (AI) can spot a serious heart valve condition called aortic stenosis using portable, non-invasive devices. Researchers will enroll 410 adults aged 70 and older during routine primary care visits. The goal is to see if AI-powered an…
Phase: NA • Sponsor: Yale University • Aim: Diagnosis
Last updated Jun 27, 2026 08:00 UTC
-
Algorithm aims to spot rare heart disease in medical records
Diagnosis TerminatedThis study aimed to test a computer algorithm that uses insurance claims data to identify people with ATTR amyloidosis, a rare disease that affects the heart and nerves. Researchers planned to check how well the algorithm worked by reviewing medical records. However, the study wa…
Phase: EARLY_PHASE1 • Sponsor: Yale University • Aim: Diagnosis
Last updated Jun 26, 2026 18:38 UTC
-
Can rewards and support keep drug users HIV-Free?
Prevention OngoingThis study tests a 24-week program called CoMPASS that uses rewards (contingency management) and extra support to help people who inject drugs take PrEP consistently for HIV prevention. About 526 participants with opioid use disorder will be enrolled. Those who don't stick with P…
Phase: NA • Sponsor: Yale University • Aim: Prevention
Last updated Jun 27, 2026 12:29 UTC
-
Can VR keep teens off vapes? yale tests a new approach
Prevention ENROLLING_BY_INVITATIONThis study tests a virtual reality (VR) program designed to help 8th graders avoid e-cigarettes and manage their emotions. Researchers at Yale University will first gather feedback from students and school staff to shape the program, then test whether it is easy to use and accept…
Sponsor: Yale University • Aim: Prevention
Last updated Jun 27, 2026 08:14 UTC
-
New AR video game aims to curb teen drinking
Prevention ENROLLING_BY_INVITATIONThis study is testing a new augmented reality (AR) video game called "No Time Wasted" to see if it can help teens aged 16-18 learn about alcohol risks and reduce dangerous drinking behaviors. Twenty high school students will play the game using an AR headset and answer surveys ab…
Phase: NA • Sponsor: Yale University • Aim: Prevention
Last updated Jun 27, 2026 07:57 UTC
-
Magnetic pulses to the brain may calm irritability
Symptom relief OngoingThis study tests whether a noninvasive technique called repetitive transcranial magnetic stimulation (rTMS) can reduce irritability by targeting brain circuits involved in frustration. About 20 adults with elevated irritability will receive rTMS while researchers measure brain ac…
Phase: NA • Sponsor: Yale University • Aim: Symptom relief
Last updated Jul 02, 2026 03:00 UTC
-
New therapy approach aims to keep minority teens in mental health care
Symptom relief ENROLLING_BY_INVITATIONThis study tests a new method called Strategic Treatment Assessment for Youth (STAY) designed to help racial and ethnic minority teens with depression or suicidal thoughts stay in therapy. Researchers will compare STAY to standard care in 140 teens aged 12-18 across three communi…
Phase: NA • Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 27, 2026 14:01 UTC
-
Nerve zapper offers hope for chronic headache sufferers
Symptom relief ENROLLING_BY_INVITATIONThis study looks at whether a 60-day nerve stimulation device placed near the back of the head can help people with stubborn headaches. Researchers will track pain levels, daily function, and how often participants need emergency care. About 300 adults with various headache types…
Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Magic mushroom compound tested for OCD in small trial
Symptom relief OngoingThis early-stage study is testing whether repeated doses of psilocybin, the active ingredient in magic mushrooms, can reduce symptoms of obsessive-compulsive disorder (OCD). Twenty-eight adults with moderate-to-severe OCD who have not responded to standard treatments will receive…
Phase: PHASE1 • Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 27, 2026 13:02 UTC
-
VR headsets aim to ease OCD brain treatment — but study pulled
Symptom relief TerminatedThis study planned to see if using virtual reality (VR) before a brain stimulation treatment called TMS could help people with OCD feel more comfortable. It was designed for adults already approved for TMS. However, the study was withdrawn before any participants were enrolled, s…
Phase: NA • Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 27, 2026 12:37 UTC
-
Talking therapy shows promise for calming outbursts in kids with autism
Symptom relief ENROLLING_BY_INVITATIONThis small pilot study at Yale University is testing a modified form of cognitive-behavioral therapy (CBT) for children with autism and intellectual disability who struggle with irritability, tantrums, and aggression. Up to 6 children aged with an IQ between 55 and 85 will receiv…
Phase: NA • Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 27, 2026 12:31 UTC
-
Can a phone app ease kidney disease stress?
Symptom relief ENROLLING_BY_INVITATIONThis study tests a digital mindfulness app called Calm Health in 26 adults with chronic kidney disease. Participants use the app for 6 weeks while wearing a wrist sensor to track sleep, activity, and heart rate. The goal is to see if the app is easy to use and if it helps reduce …
Phase: NA • Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 27, 2026 12:24 UTC
-
New combo therapy aims to cut pain and opioid use in chronic sufferers
Symptom relief OngoingThis study tests a 24-week program called SC-POWR for 204 adults with opioid use disorder and chronic pain. Participants get medication, therapy, exercise (like Wii Fit and Tai Chi), and stress reduction (relaxation training and acupuncture). The goal is to reduce pain interferen…
Phase: NA • Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 27, 2026 12:24 UTC
-
Can a simple ointment before surgery lead to better scars?
Symptom relief ENROLLING_BY_INVITATIONThis study looks at whether applying a silicone ointment to the skin before head and neck surgery helps wounds heal with less scarring. About 60 adults having non-emergency surgery will take part. Researchers will compare scars using standard rating scales and also track hospital…
Phase: NA • Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
New ER tool aims to tame agitation without restraints
Symptom relief TerminatedThis pilot study tests a tool called ED-TREAT that helps emergency room staff spot and treat agitation early. The goal is to see if the tool is easy to use and can reduce the need for physical restraints. The study involves 26 adults at Yale New Haven Hospital, but enrollment is …
Phase: NA • Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 27, 2026 11:01 UTC
-
Pain relief study for IUD insertion pulled before it started
Symptom relief TerminatedThis study planned to test whether a small electrical device (TENS) could reduce pain when placing an IUD. It was designed for adults getting a new or replacement IUD. The study was withdrawn before enrolling anyone, so no results are available.
Phase: NA • Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 27, 2026 09:05 UTC
-
Beating stress: drum circles tested as anxiety relief for marginalized groups
Symptom relief ENROLLING_BY_INVITATIONThis study looks at whether joining community drum circles and mindfulness programs can help reduce anxiety and depression in Black and other marginalized groups who faced extra stress during COVID-19. About 90 people aged 16 and older will take part. Researchers will measure how…
Phase: NA • Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 27, 2026 09:05 UTC
-
Live music may soothe Alzheimer's patients and caregivers, yale study hints
Symptom relief ENROLLING_BY_INVITATIONThis study from Yale University will test whether listening to live music can reduce anxiety and improve brain activity in people with early Alzheimer's disease, dementia, or mild cognitive impairment, along with their caregivers. Sixty pairs (patient and caregiver) will attend b…
Phase: NA • Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 27, 2026 09:04 UTC
-
Music and mindfulness program aims to ease stress in african american communities
Symptom relief ENROLLING_BY_INVITATIONThis study tests whether a virtual, community-based program combining music and mindfulness can help reduce stress, anxiety, and depression in people of African descent. About 300 participants aged 16 and older will take part. The goal is to see if these culturally relevant activ…
Phase: NA • Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 27, 2026 09:04 UTC
-
Can vyvanse curb Post-Surgery binge eating? new trial aims to find out
Symptom relief OngoingThis study tests whether the medication lisdexamfetamine (Vyvanse) can help people who experience loss-of-control eating after bariatric surgery and didn't improve with earlier treatments. About 60 adults who had gastric bypass or sleeve gastrectomy will receive either the drug o…
Phase: PHASE2, PHASE3 • Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 27, 2026 09:01 UTC
-
Botox study for skin disease pulled before it started
Symptom relief TerminatedThis study aimed to see if Botulinum Toxin-A (Botox) could help people with hidradenitis suppurativa, a painful skin condition. It planned to enroll adults with active armpit lesions of similar severity on both sides. However, the study was withdrawn before any participants were …
Phase: PHASE4 • Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 27, 2026 08:04 UTC
-
Magic mushroom compound shows promise for tough depression
Symptom relief OngoingThis small pilot study tests whether psilocybin, the active ingredient in magic mushrooms, can change brain connections to improve depression. 18 adults with major depression who didn't get better with standard treatments will receive psilocybin. Researchers will measure brain ac…
Phase: PHASE1 • Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 27, 2026 07:56 UTC
-
Can a posture device replace surgery for cubital tunnel syndrome?
Symptom relief TerminatedThis study tests whether the UpRight Go posture trainer, a wearable device that vibrates when you slouch, can reduce pain, numbness, and weakness in people with cubital tunnel syndrome who haven't had surgery. Researchers at Yale University plan to enroll 40 adults and track symp…
Phase: NA • Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 26, 2026 17:38 UTC
-
Can a video help older women decide on breast cancer screening?
Knowledge-focused OngoingThis study tests whether a video or a written guide helps women aged 75 and older make better decisions about breast cancer screening. About 300 women who have had screening before but never had breast cancer will take an online survey. The goal is to see which format reduces con…
Phase: NA • Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Ketamine's brain impact under the scanner: new study targets synaptic loss
Knowledge-focused OngoingThis study uses PET and MRI scans to measure brain cell connections in people with major depression or PTSD. Researchers will give ketamine to see if it can reverse synaptic loss linked to these conditions. The goal is to understand brain changes, not to provide treatment. About …
Phase: NA • Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:05 UTC
-
New study probes emotional impact of Cutting-Edge prostate cancer scans
Knowledge-focused OngoingThis study looks at how a new, more sensitive type of PET scan (PSMA PET) affects the anxiety, decision-making, and quality of life of 350 men with prostate cancer. Participants will fill out surveys about their feelings and experiences over a year. The goal is to understand the …
Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:38 UTC
-
New study tests whether Family-Focused support helps IPV survivors more
Knowledge-focused OngoingThis study looks at whether a family-centered approach helps caregivers affected by intimate partner violence (IPV) engage more with support services compared to a child-centered approach. About 95 caregivers with children under 5 who were reported to child protective services fo…
Phase: NA • Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
MDMA brain study on PTSD never got off the ground
Knowledge-focused TerminatedThis study aimed to see how MDMA changes brain activity in people with PTSD, especially in areas that handle emotions. Researchers planned to give MDMA to a small group and measure brain scans and PTSD symptoms. However, the study was withdrawn before any participants were enroll…
Phase: PHASE1 • Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:35 UTC
-
Can artificial intelligence predict heart valve disease progression?
Knowledge-focused ENROLLING_BY_INVITATIONThis study will enroll 210 adults aged 65 and older with early aortic stenosis (a heart valve narrowing) to see if an artificial intelligence tool can better predict how fast the disease worsens. Participants will have standard echocardiograms, and researchers will compare the AI…
Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
Emergency rooms test new way to protect seniors from dangerous drugs
Knowledge-focused OngoingThis study looks at whether giving doctors feedback about their prescribing habits can reduce the number of potentially harmful medications given to older adults when they leave the emergency department. About 200 clinicians from Yale New Haven Health System are taking part. The …
Phase: NA • Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Study tests how a drink and a puff impact your driving
Knowledge-focused OngoingThis study looks at how small amounts of alcohol and THC (the active part of cannabis) affect driving in a simulator. Forty adults aged 21 to 55 who have used both substances before will take part. The goal is to understand how these drugs change driving performance and thinking,…
Phase: PHASE1 • Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:25 UTC
-
Study reveals how booze and weed impair your driving
Knowledge-focused OngoingThis study looks at how alcohol and cannabis, alone or together, affect driving ability and thinking. About 40 occasional cannabis users who also drink alcohol will use a driving simulator after taking controlled doses. The goal is to understand the risks of driving under the inf…
Phase: PHASE1 • Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:25 UTC
-
Yale scans brains of synthetic pot users to uncover addiction clues
Knowledge-focused OngoingThis observational study at Yale uses PET brain scans to measure CB1 receptor availability in 15 people who currently use synthetic cannabinoids. Researchers want to see if these receptors are lower in users and how that relates to thinking skills and brain rhythms during withdra…
Phase: NA • Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:25 UTC
-
Study reveals how booze and weed mess with your driving
Knowledge-focused OngoingThis study looks at how alcohol and cannabis, alone or together, affect driving and thinking. About 40 occasional users aged 21–55 will take part. They will inhale low-dose THC (like a quarter of a joint) and drink alcohol, then test their driving on a simulator and complete ques…
Phase: PHASE1 • Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC
-
THC study aims to unravel Cannabis's impact on memory
Knowledge-focused OngoingThis study at Yale University looks at how THC, the active ingredient in cannabis, affects short-term and long-term memory. Researchers will give 80 adults who have used cannabis before either a low dose of THC or a placebo and then test their memory. The goal is to better unders…
Phase: PHASE1 • Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC
-
Study reveals how booze and weed impair your driving
Knowledge-focused OngoingThis study looks at how alcohol and cannabis, alone or together, affect driving ability and thinking. About 40 adults aged 21–55 who have used both substances before will take part. They will complete simulated driving tests and questionnaires after receiving the substances. The …
Phase: PHASE1 • Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC
-
Can a simple screening help adult students overcome depression and stay in school?
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at whether a program called SBIRT (Screening, Brief Intervention, and Referral to Treatment) can help adult education students with behavioral health issues like depression, anxiety, and substance use. About 340 students and staff from New Haven Adult Education w…
Phase: NA • Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
Scientists hunt for hidden genes behind aortic aneurysms
Knowledge-focused OngoingThis study aims to uncover the genetic roots of aortic aneurysms and valve disease by analyzing tissue and blood samples from 3,000 participants. Researchers will look for new disease-causing genes and factors that affect disease severity. The goal is to build a biorepository to …
Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:04 UTC
-
Drum circles and meditation: a new way to beat stress?
Knowledge-focused ENROLLING_BY_INVITATIONThis study explores whether listening to recordings of communal drumming, combined with mindfulness, can reduce stress and improve mental health in People of African Descent. Researchers will measure feelings of connection and synchrony in 30 adults. The goal is to see if cultura…
Phase: NA • Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:04 UTC
-
Brain zaps may boost social skills in autism
Knowledge-focused OngoingThis study tests whether a non-invasive brain stimulation technique called repetitive Transcranial Magnetic Stimulation (rTMS) can change how adults with autism process social information. Researchers will measure brain responses with EEG and eye-tracking before and after stimula…
Phase: NA • Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:01 UTC
-
Mystery chest pain: study digs deeper to find hidden heart problems
Knowledge-focused OngoingThis study involves 500 people who have chest pain or other signs of heart trouble, but whose main heart arteries are not blocked. Researchers use special tools during a heart catheterization to measure tiny blood vessel function and look for hidden causes like microvascular dise…
Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:05 UTC
-
Which heart test is best for women? new study aims to find out
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at 500 women with chest pain to compare two tests used during heart catheterization—FFR and iFR—to see which better predicts future heart problems like heart attacks or strokes. Participants will be followed for 5 years. The goal is to improve how doctors decide …
Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:56 UTC
-
Blood test may spot tiny heart blockages in transplant patients
Knowledge-focused TerminatedThis study aimed to see if a simple blood test could find blockages in the small blood vessels of the heart in people who have had a heart transplant. Participants would have had blood draws every three months for a year, and their medical records would have been reviewed for thr…
Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:56 UTC
-
Cannabis study aims to unlock HIV immune secrets
Knowledge-focused OngoingThis study looks at how cannabis (specifically the drug Dronabinol) changes the immune system and genes in people with HIV. Researchers will take blood samples before and after giving Dronabinol to 160 participants. The goal is to understand these changes better, which could help…
Phase: PHASE1 • Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:56 UTC
-
Massive study aims to predict and understand seizures after stroke
Knowledge-focused ENROLLING_BY_INVITATIONThis study gathers information from 8,000 stroke patients worldwide to learn more about seizures that happen after a stroke. Researchers will analyze the data to see how well patients recover and to create a tool that can predict who might develop epilepsy. The goal is to improve…
Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:55 UTC
-
New study aims to set better standards for treating severe leg artery disease
Knowledge-focused OngoingThis study is collecting information from 458 people with critical limb-threatening ischemia, a severe form of peripheral artery disease that can lead to amputation. The goal is to learn how different treatments affect patients' daily lives and health outcomes. Researchers hope t…
Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:55 UTC
-
Writing away burnout? study for PA students pulled before it began
Knowledge-focused TerminatedThis study was designed to test whether a guided reflective writing program could reduce burnout in physician assistant students at Yale. The plan was to have students attend three 75-minute writing workshops and measure changes in burnout using a standard questionnaire. However,…
Phase: NA • Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 26, 2026 12:41 UTC